Eucrisa and Acne - a phase IV clinical study of FDA data

Summary:

Acne is reported as a side effect among people who take Eucrisa (crisaborole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Dupixent, and have Eczema.

The phase IV clinical study analyzes which people have Acne when taking Eucrisa. It is created by eHealthMe based on reports of 9,895 people who have side effects when taking Eucrisa from the FDA, and is updated regularly.

What is Eucrisa?

Eucrisa has active ingredients of crisaborole. eHealthMe is studying from 9,900 Eucrisa users. Check the latest studies of Eucrisa.

What is Acne?

Acne (skin problems that cause pimples) is found to be associated with 1,313 drugs and 2,348 conditions by eHealthMe. Check the latest studies of Acne.

On Jul, 13, 2026

9,895 people reported to have side effects when taking Eucrisa.
Among them, 38 people (0.38%) have Acne.

Among these 38 people:

How long have people been on Eucrisa when they have Acne? *

What is the gender of people who have Acne when taking Eucrisa? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Acne when taking Eucrisa? *

What are other drugs people take besides Eucrisa? *

What are other side effects people have besides Acne? *

Drug Ineffective: 5 people, 13.16%
Itching: 4 people, 10.53%
Rashes (redness): 4 people, 10.53%
Folliculitis (infection of hair root): 3 people, 7.89%
Skin Irritation: 3 people, 7.89%
Application Site Pruritus (application site severe itching of the skin): 2 people, 5.26%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 5.26%
Application Site Pain: 2 people, 5.26%
Burning Sensation: 2 people, 5.26%
Rhinorrhea (watery mucus discharge from the nose): 2 people, 5.26%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 11 people, 28.95%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 9 people, 23.68%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 7.89%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 3 people, 7.89%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 5.26%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Eucrisa and have Acne?

- Check whether Acne is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eucrisa:

Eucrisa (9,900 reports)

Acne treatments and more:

Acne (179,011 reports)

Browse all side effects of Eucrisa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acne:

Acne (1,313 drugs)

Browse all the conditions that are associated with Acne:

Acne (2,348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crisaborole (the active ingredients of Eucrisa) and Eucrisa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.